Avax Apparels (544337)

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 34.58% and profit growth of 31.87% demonstrate strong momentum.
• ROCE of 43.81% shows highly efficient use of capital.
• Piotroski F-Score of 7/9 points to sound fundamentals despite limited disclosure.
• PEG of approximately 0.50 suggests growth is available at a reasonable valuation.
• Latest quarter remains profitable with ₹20 Cr sales and ₹1 Cr net profit.

Concerns

• Critical data missing: book value, debt-to-equity, and promoter holding are unavailable, preventing a proper balance-sheet assessment.
• Zero dividend yield provides no income cushion for minority shareholders.
• Textile apparel is a highly competitive, low-moat industry with thin net margins around 5%.
• Extremely small market cap of ₹32 Cr raises liquidity and price manipulation risks.

AI Analysis

At ₹311.40, Avax Apparels carries a market cap of only ₹32 crore—a microcap, and the first lesson Graham taught is that small size can be either a blessing or a trap. The business shows real momentum: sales up 34.58%, profit up 31.87%, and a Piotroski F-Score of 7/9 suggests decent financial health. ROCE of 43.81% is genuinely impressive; it indicates that capital is being put to work effectively. The P/E of 16.77, coupled with that growth, gives a PEG near 0.50—an attractive price for a fast grower, but only if the numbers are reliable. However, I cannot ignore what is missing. There is no book value, no debt-to-equity ratio, no promoter holding, and no dividend. In Graham's world, the absence of data is not neutral; it is a yellow flag. A 5% net margin on latest quarter sales of ₹20 crore is thin, so any input-price shock could squeeze earnings quickly. Textile apparel is a brutally competitive, low-moat industry with shifting tastes and global competition. The 52-week range is unavailable, so I cannot assess volatility or support levels. I would not write a big cheque here. The valuation is not obviously crazy, and the growth is real on paper, but the disclosure gap is too large for a long-term investor. If the company continues compounding at 30% and provides fuller balance-sheet details, it could become interesting. Until then, this remains a watch-list candidate for the risk-tolerant small investor, not a core Buffett holding. In business, you pay a fair price for a wonderful business; here I am being asked to pay a fair price for data I cannot verify.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer